SCHEMBL30768439

SCHEMBL30768439

COC(OC)C1CCN(c2ccc(C3=C(c4cccc5c4CCCC5)CCc4cc(OCc5ccccc5)ccc43)cc2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 1/20 0.41
GRIN2B Q13224 1/20 0.41
ESR1 P03372 7/20 0.41
GYS1 P13807 1/20 0.40
EBP Q15125 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
ADRA1D P25100 1/20 0.37
ADRA1A P35348 1/20 0.37
ADRA1B P35368 1/20 0.37
GPR84 Q9NQS5 1/20 0.37
USP2 O75604 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
ESR2 Q92731 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
HRH3 Q9Y5N1 4/20 0.36
CYP2D6 P10635 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30768627 0.98 ESR1 (0.42) GRIN1GRIN2BESR1GYS1EBP
SCHEMBL30769116 0.96 EBP (0.40) GRIN1GRIN2BESR1GYS1EBP
SCHEMBL30769426 0.89 ADRA1D (0.44) GRIN1GRIN2BESR1EBPSIGMAR1
SCHEMBL29632097 0.88 EBP (0.49) GRIN1GRIN2BESR1EBPSIGMAR1
SCHEMBL20211928 0.88 EBP (0.49) GRIN1GRIN2BESR1EBPSIGMAR1
SCHEMBL30768653 0.87 ESR1 (0.46) GRIN1GRIN2BESR1EBPSIGMAR1
SCHEMBL30769280 0.86 HRH3 (0.45) GRIN1GRIN2BESR1EBPSIGMAR1
SCHEMBL30768962 0.86 ESR1 (0.52) GRIN1GRIN2BESR1EBPSIGMAR1
SCHEMBL30769002 0.85 ESR1 (0.46) GRIN1GRIN2BESR1EBPSIGMAR1
SCHEMBL30340457 0.85 EBP (0.44) GRIN1GRIN2BESR1EBPSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543871-A1 ESTROGEN RECEPTOR ALPHA DEGRADERS AND USE THEREOF Relay Therapeutics, Inc. (US) 2025-04-30 EP disclosed
WO-2024006781-A1 ESTROGEN RECEPTOR ALPHA DEGRADERS AND USE THEREOF RELAY THERAPEUTICS, INC. (US) 2024-01-04 WO disclosed